The global Influenza Diagnostics Market was valued at USD 508.87 million in 2016 and is projected to reach USD 1063.61million by 2025, growing at a CAGR of 8.56% from 2017 to 2025.
With increasing prevalence of infectious diseases and initiatives towards treatment and efficient diagnosis of Influenza, the demand of diagnostic services has increased all over the globe. The market is thus expected to grow during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Prevalence of Influenza
1.2 Growth in Research Funding for Influenza Diagnostics
1.3 Rising Demand for Faster Diagnosis and Control of Influenza
2. Market Restraints
2.1 Variability in Sensitivity and Specificity Among Influenza Diagnostic Tests
2.2 Stringent Regulatory Framework
2.3 Rising Healthcare Costs Limiting the Usage of Novel Influenza Diagnostic Techniques
Market Segmentation:
1. Global Influenza DiagnosticsMarket, by End User:
1.1 Hospitals/Clinical Laboratories
1.2 Reference Laboratories
1.3 Other End Users
2. Global Influenza DiagnosticsMarket, by Test Type:
2.1 Traditional diagnostic tests
2.1.1 Rapid Influenza Detection Tests (RIDT)
2.1.2 Viral Culture
2.1.3 Direct Fluorescent Antibody (DFA) Tests
2.1.4 Serological Assays
2.2 Molecular Diagnostic tests
2.2.1 RT-PCR
2.2.2 Nucleic Acid Sequence-Based Amplification (NASBA) Tests
2.2.3 Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
2.2.4 Simple Amplification-Based Assays (SAMBA)
2.2.5 Other Molecular Diagnostic Tests
3. Global Influenza Diagnostics Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG
2. Becton, Dickinson and Company
3. Thermo Fisher Scientific Inc.
4. Alere Inc.
5. Diasorin S.P.A.
6. Quidel Corporation
7. Meridian Bioscience, Inc.
8. Analytik Jena AG (A Subsidiary of Endress+Hauser AG)
9. Luminex Corporation
10. SA Scientific, Ltd.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Influenza DiagnosticsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL INFLUENZA DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL INFLUENZA DIAGNOSTICSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY END USER
5.1 Hospitals/Clinical Laboratories
5.2 Reference Laboratories
5.3 Other End Users
6 GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE
6.1 Traditional diagnostic tests
6.1.1 Rapid Influenza Detection Tests (RIDT)
6.1.2 Viral Culture
6.1.3 Direct Fluorescent Antibody (DFA) Tests
6.1.4 Serological Assays
6.2 Molecular Diagnostic tests
6.2.1 RT-PCR
6.2.2 Nucleic Acid Sequence-Based Amplification (NASBA) Tests
6.2.3 Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
6.2.4 Simple Amplification-Based Assays (SAMBA)
6.2.5 Other Molecular Diagnostic Tests
7 GLOBAL INFLUENZA DIAGNOSTICSMARKET, BY GEOGRAPHY
7.1 Overview
7.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
8 GLOBAL INFLUENZA DIAGNOSTICSMARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 F. Hoffmann-La Roche AG
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Becton, Dickinson and Company
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Thermo Fisher Scientific Inc.
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Alere Inc.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Diasorin S.P.A.
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Quidel Corporation
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Meridian Bioscience, Inc.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Analytik Jena AG (A Subsidiary of Endress+Hauser AG)
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Luminex Corporation
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 SA Scientific, Ltd.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 Appendix
10.1 Related Reports
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The In Vitro Diagnostics Analyzers Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Tuberculosis Diagnostics Testing Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Companion Animal Diagnostics Imaging Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The In Vitro Diagnostics (IVD) Tests For Autoimmune Diseases Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, c...
The Digital Diagnostics System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Liver Disease Diagnostics Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...